Objective: This study validates different definitions of reported night blindness (XN) in a vitamin A deficient African population with no local term for XN. Design: Case-control study with follow-up after treatment. Setting: Eight primary schools and health centres in rural Tanzania. Subjects: A total of 1214 participants were screened for reported XN and other eye signs of xerophthalmia: 461 children aged 24-71 months, 562 primary school-age children and 191 pregnant or breast-feeding women. All 152 cases of reported XN were selected for the validation study and group matched with 321 controls who did not complain of XN. XN reports were validated against serum retinol concentrations and pupillary dark adaptation measurements in cases and controls. Intervention: All children and women who reported XN or had other signs of active xerophthalmia were treated with vitamin A and followed up 3-4 weeks later. Half of the untreated control group who had their serum retinol examined in the baseline examination were also followed up. Results: The overall prevalence of reported XN was 12.5%. At baseline, mean pupillary threshold (-1.52 vs -1.55 log cd/m 2 , P ¼ 0.501) and median serum retinol concentrations (0.95 vs 0.93 mmol/l, P ¼ 0.734) were not significantly different in cases and controls either overall or in each population group. More restricted case definitions reduced the prevalence of reported XN to 5.5% (Po0.001), but there was still no significant difference between cases and controls although the results were in the expected direction. After treatment, the median serum retinol concentration improved significantly only in the most deficient group, the young children. Dark adaptation improved in all the subgroups but the difference was only significant for young children and primary school-age children when the restricted case definitions were used. Conclusions: XN reports are a poor indicator of vitamin A deficiency in this population. Sponsorship: Task Force Sight and Life, Basel, Switzerland.
Background
Night blindness (XN) or impaired dark adaptation is the first functional manifestation of vitamin A deficiency (VAD) that can be measured clinically (World Health Organization, 1996) . Rhodopsin is a membrane protein in the retinal photoreceptors called rods that are primarily responsible for peripheral vision and for vision at low levels of light. It is activated by light and initiates the visual response via neural impulses to the brain. Rhodopsin is produced in the rod in the dark and enables us to see at low levels of light. This process is also called dark adaptation. Retinal, one of the active metabolites of vitamin A, is a necessary structural component of rhodopsin. As the synthesis of rhodopsin depends on the availability of retinal, VAD leads to impaired dark adaptation.
XN reports in young children have been advocated as a simple, inexpensive and reliable indicator of VAD in populations with a specific term for XN in the local language (Sommer et al, 1980; World Health Organization, 1996) . However, the evidence to support this has mainly come from one large validation study in 5925 Indonesian children aged 0-6 y (Sommer et al, 1980) . Reported XN in pregnant women has recently been recommended as a simple tool to identify vitamin A deficient populations (Christian, 2002) .
Previous surveys have used a range of definitions and different ways of asking for XN to evaluate the vitamin A status of populations with and without a local term for XN (Sinha & Bang, 1976; Pant & Gopaldas, 1986; Tielsch et al, 1986; Lloyd-Puryear et al, 1991; Katz et al, 1995) . However, different methods, definitions and awareness of XN in a population are likely to influence the validity of XN reports.
This study attempted to establish whether reported XN was a valid indicator of the vitamin A status of an African population with no local term for XN. It compared different definitions of XN in three population groups at risk of VADFpreschool children aged 2-5 y, primary school-age children and pregnant/breast-feeding womenFand validated them against serum retinol concentrations and pupillary threshold measurements.
Methods

Study site and study participants
The study took place in Misungwi District in rural Mwanza Region, Tanzania. Eight primary schools and health centres were purposively selected to be inland, well away from Lake Victoria. VAD is known to be prevalent in this area, but there is no word for XN in Sukuma, the main local language (Ballart et al, 1998; Wedner & Ross, 2002) . All primary school children attending the study schools, all other children aged 2-15 y, women who were in the last trimester and women breast-feeding an infant of less than 6 months were eligible for the study. They were requested to attend an eye clinic that was held in either a health facility or one of the selected primary schools. Invitations were sent out to the population through the students, through antenatal and child health clinics and through the village leaders. To avoid overreporting, XN (impaired vision at low levels of light) was not mentioned as one of the symptoms of vitamin A deficiency either in the information leaflets or in the invitation letters. Between 14 November and 1 December 2001, 1214 participants were screened. All participants who had their blood taken in the baseline survey were eligible for the follow-up survey that was carried out from 11 to 21 December 2001. Research and Ethics clearances had been obtained from the National Institute for Medical Research, Mwanza Centre, the Medical Research Coordinating Committee of Tanzania, the Institutional Review Board of the Johns Hopkins University and the London School of Hygiene and Tropical Medicine.
Baseline survey
Definition of night blindness. Having obtained informed consent, separate questionnaires were sent to each of the three population groups: young children (24-71 months), primary school-age children, and pregnant or breast-feeding women. The presence of XN was assessed using a slightly modified version of the algorithm suggested by WHO (World Health Organization, 1996) . The algorithm used consisted of three questions:
1. Do you/does your child have any problem seeing in the daytime? 2. Do you/does your child have any problem seeing in the evening or in low levels of light? 3. If (2) ¼ yes: Is this problem different from most other children/women in your community?
The fourth question of the WHO algorithm that enquires about XN using the local term was omitted, as there is no such local term.
Proxy reports from parents or guardians were used for children aged less than 8 y. All participants who complained of having a problem seeing in low levels of light but no problem seeing during the day (main case definitionFMCD) were defined as cases. All the cases were asked to give examples of the problem (spontaneous complaints). If no spontaneous complaints were reported, they were asked whether, in low levels of light, they were able to see something (eg food) that had been put in front of them, were able to play or work, or were prone to walk into or to trip over objects (prompted complaints) .
In addition to the MCD, three alternative more restricted case definitions (RCD1-3) were analysed:
RCD1 No problems seeing during the daytime, but problems seeing in low levels of light, which were different from most other children/women in their community.
RCD2 No problems seeing during the daytime, but problems seeing in low levels of light, and at least one specific complaint from the above list that was reported spontaneously.
RCD3 No problems seeing during the daytime, but problems seeing in low levels of light which were different from other children/women in their community, and at least one specific complaint from the above list that was reported spontaneously.
RCD1 is the closest to the definition of XN that is currently recommended by WHO (World Health Organization, 1996) . All participants who did not have a problem seeing both during the day and in low levels of light were eligible to be controls. Young children (2-5 y) were group-matched by age and sex to make sure that there were twice as many controls as cases of each sex in eight 6-month age groups. Primary school students were group-matched by sex within the same school year. Other primary school-age children (6-15 y) were group-matched by age and sex in seven age groups (see Table 1 ). Women were group-matched based on whether they were pregnant or breast-feeding. The proportions of cases and controls were similar in pregnant and breastfeeding women using the MCD, and RCD2 and 3. For simplicity, pregnant and breast-feeding women have been combined in the analysis for all four case definitions.
Eye examination. An ophthalmic nursing officer then examined the 1211 participants for signs of xerophthalmia (Bitot's spots, corneal xerosis, ulcers and scars). In the analysis, all seven participants with Bitot's spots were included as a case or a control according to their XN report.
Pupillary threshold measurements
The pupillary threshold (scotopic sensitivity) was measured by observing the consensual pupil response to a lightemitting diode with 11 different settings at 0.3 log unit intervals. Participants had been dark-adapted for 10 min after exposure to a camera flash. A standard test protocol developed by Congdon et al (1995) was used. All the examinations were carried out by the same examiner, a sixth-form secondary school leaver with previous research experience who was not aware of the participants' XN status. He and the ophthalmologist (SW) had been trained and standardised by an experienced external examiner from Johns Hopkins University, Baltimore during a pilot study. Calibration of the pupillary threshold device was reconfirmed by the manufacturer at the end of the study.
Serum retinol measurements
Following the pupillary threshold test, 500-600 ml of blood was taken by finger prick from all the cases, all the participants with Bitot's spots and from one of each pair of controls, who was chosen randomly. The blood was collected into one labelled, amber 0.6 ml microtube containing a serum separator gel (Beckton Dickinson Microtainers) and kept on ice until it had been transported to the laboratories of the National Institute for Medical Research, Mwanza at the end of each day, where it was centrifuged within 10 h of collection. The serum from each participant was divided into two aliquots of 150-250 ml and stored in screw-topped containers (Greiner) that were wrapped in aluminium foil, and frozen at -201C. The specimens were transported on dry ice to the laboratories of Roche Vitamins in Basel within 2 months of collection, where retinol was analysed using standard HPLC methods at the VFHA Bioanalytics Laboratory of Roche Vitamins (Aebischer et al, 1999) . The intra-and interday repeatability for the analysis has been shown to be less than 3 and 6%, respectively.
Quality control. The ophthalmologist (SW) repeated 8% of the questionnaires, 7% of the eye examinations and 13% of the pupillary threshold measurements, all randomly selected.
Treatment. All children and women who reported XN or had other signs of active xerophthalmia (eg Bitot's spot) were treated with vitamin A: children and women up to 4 weeks postpartum with a total of three capsules of 200 000 IU vitamin A on day 1, 2 and 14 and all the other women with vitamin A tablets 10 000 IU daily for 30 days.
Follow-up survey
All cases and controls who had their serum retinol concentration measured in the baseline survey were given an appointment for re-examination 3-4 weeks after their baseline examination. Participants were asked again about their XN status using the same questions as in the baseline survey, their eyes were examined for clinical signs of xerophthalmia, and they underwent pupillary dark adaptation testing. Finger prick blood specimens were taken from all participants. Controls who now complained of XN were treated with vitamin A. All procedures and treatment regimens were the same as in the baseline survey.
Data analysis
All data were independently entered on to computers by two data entry clerks and were checked for discrepancies to minimise data entry errors. Range and consistency checks were performed on all data. DBASE 4 (Borland International, Scotts Valley, CA, USA) and STATA 7.0 (Stata Corporation, College Station, TX, USA) were used for data entry and analysis.
Means and 95% confidence intervals were used to describe normally distributed data; medians and 95% confidence intervals were calculated using a binomial method that makes no assumption on the underlying distribution, for data that were not normally distributed (Altman, 1991) . w 2 tests with Yates correction and Fisher's exact test were used to compare proportions, while t-tests or one-way analysis of variance were used to compare means for normally distributed data. Data that were not normally distributed were analysed with nonparametric tests: Wilcoxon's rank-sum test for unpaired observations, Kruskall-Wallis one-way analysis of variance or Cuzick test for trend. Follow-up data were analysed by regression analysis. Two-sided tests were used throughout.
Sample size
With 50 cases and 50 controls it was estimated that the study would have greater than 90% power to detect a serum retinol concentration of 0.6. mmol/l for cases and of 0.8 mmol/l for controls as being significantly different at the 5% level. Prior to the study, we estimated that there would be 50% fewer cases for the more restricted definition (RCD1-3), and selected the sample size such that the power would still be at least 80% if this was the situation. In practice, the number of cases (with reported XN) for the three RCDs varied from 13 to 29 in young children, from 8 to 24 in primary schoolage children and from 3 to 14 in pregnant/breast-feeding women (Table 2) .
Results
Screened population: prevalence of xerophthalmia A total of 1214 participants were screened for XN and other eye signs of xerophthalmia: 461 young children, 562 primary school-age children, 65 pregnant and 126 breast-feeding women (Table 1) . A total of 152 cases of reported XN (12.5% of the screened population) were identified using the MCD (no problems seeing during the daytime, but problems seeing in low levels of light). None of the participants who fulfilled the eligibility criteria was rejected. Refusals were very rare. One pregnant woman (control) and one primary school student (case) refused to participate and were replaced.
The prevalence of reported XN was 11.7% in children between 24 and 71 months, 9.1% in primary school-age children and 24.6% in women (Table 2) . Even though more boys than girls reported XN among young children (14.0 vs Restricted case definition 1 (RCD1): Participants complained about problems seeing in low levels of light, but no problem seeing during the day and claimed that their problem was different from other people in their community. Restricted case definition 2 (RCD2): Participants complained about problems seeing in low levels of light, but no problem seeing during the day and, in addition, they complained spontaneously about at least one of the following problems: falling over, not able to play or work, cannot find something put in front of them (eg food) in low levels of light. Restricted case definition 3 (RCD3): Participants complained about problems in low levels of light which were different from other people in their community, but no problem seeing during the day and, in addition, they complained spontaneously about at least one of the following problems: falling over, not able to play or work, cannot find something put in front of them (eg food) in low levels of light. Table 2 ). Applying the first restricted case definition, which is the most similar to the recommended WHO definition (RCD1: no problems seeing during the daytime, but problems seeing in low levels of light, among individuals who claimed that their problems were different from other children/women in their community), decreased the prevalence in all groups. It decreased significantly by about half in children and by more than two-thirds in women (Po0.001, one-sample test of proportions; Table 2 ). Nearly half the cases did not know whether their problem was different from other members in their community (69/152, 45.4%), while 67 participants (44.1%) said that they were different, and only 13 (8.6%) said they were not different. The proportion of cases who claimed that they did not know whether they were different from their peers was high in all groups: 41% of young children, 37% of primary school-age children and 60% of women. The proportion of cases who reported that their problem was not different from other members of their community was low in all the population groups: 6% of young children, 14% of primary school-age children and 7% of women. Bitot's spots, all in the temporal conjunctiva, were present in seven of the 1214 participants (0.6%, Table 2 ): three in young children, three in primary school-age children and one in a breast-feeding woman. The six children with Bitot's spots (all aged less than 7 y) had a significantly lower median serum retinol concentration than children aged less than 7 y without Bitot's spots (0.50 vs 0.70 mmol/l; P ¼ 0.013, twosample Wilcoxon's rank-sum test). Two participants with Bitot's spots complained of XN (one young child and one primary school-age child) and five claimed not to have any problems seeing during the evening (two young children, two primary school-age children and one breast-feeding woman). All those with Bitot's spots were treated with vitamin A. Five were seen at follow-up: two young children, two primary school-age children and one woman. Only one Bitot's spot in a young child had resolved.
None of the participants had active corneal signs of xerophthalmia. Corneal scars of any kind were present in 11/1211 (0.9%) of the screened population, with the prevalence ranging from 0.4% in young children to 1.4% in primary school-age children ( Table 2) . Six of the 10 children with corneal scars were boys. Serum retinol concentration was only available in all three cases (reported XN) with corneal scars, and their median concentration was not significantly lower than the median of cases without corneal scars or Bitot's spots (0.77 vs 0.86 mmol/l; P ¼ 0.414, two-sample Wilcoxon's rank-sum test). By chance, none of the eight controls with corneal scars were selected for serum retinol measurement.
Cases and controls: demographic characteristics
All 152 cases of reported XN were selected for the validation study and group-matched with 321 controls. As a result of this, the distribution of age and sex was similar for cases and controls at the baseline survey in both groups of children (Table 1a) . Among young children, more of the cases were boys than girls (58.2 vs 41.8%; P ¼ 0.034). Conversely, among the primary school-age children, more of the cases were girls (66.0 vs 34.0%; Po0.001). For each school year, the median age of school-attending children was similar to the median age of nonschool-attending children. In pregnant and breast-feeding women, the median age, number of children and birth intervals were all similar in cases and controls (Table 1b ). The median ages of the women in the two study groups were 24-26 y. They had, on average, two to three children, with a median time interval to the last-born child of 32-37 months.
Pupillary threshold measurements
At baseline, pupillary threshold results were available for 146 (96.1%) of the cases and 309 (96.3%) of the controls.
Except for children between 24 and 35 months, acceptability of the pupillary threshold test was very good, with more than 96% of participants completing the test. However, only 58% of the 26 children aged 24-35 months completed the test at baseline and 79% at follow-up. Of the 455 pupillary threshold measurements, 60 (13.2%) were remeasured by the ophthalmologist immediately after the main examiner had completed his measurement. In 54 (90%) participants, the score was identical. None of the discrepant measurements was more than one score different.
Pupillary thresholds are measured in log candela/m 2 (log cd/m 2 ). The more negative the measurement, the lower the pupillary threshold and the better the dark adaptation of the participant. The mean pupillary threshold was worse in young children (-1.45 log cd/m 2 ) than in primary school-age children (-1.57 log cd/m 2 ) and women (-1.60 log cd/m 2 ) (P ¼ 0.011, one-way analysis of variance; Table 2 ).
Micronutrient status
Half the controls (159 ( ¼ 49.5%)). were randomly selected for measurement of their serum retinol concentration. Serum retinol concentrations were lowest in young children (0.67 mmol/l), and higher in primary school-age children (0.93 mmol/l) and in pregnant/breast-feeding women (1.13 mmol/l) (Po0.001, one-way analysis of variance). In primary school-age children, median serum retinol concentrations increased with age (P ¼ 0.027; Table 2 ) and were higher in girls than in boys (Po0.001; Table 2 ).
Validation of XN reports vs serum retinol concentrations and pupillary thresholds
Full baseline data (ie eye examination, completed pupillary threshold test and serum retinol results) were available from (95.6%). The medians and distributions of serum retinol concentrations and the means of pupillary threshold measurements were compared between cases and controls in each of the three population groups: young children, children of primary school age and women. Neither the median serum retinol concentration nor the proportions whose serum retinol concentration was below 0.35 mmol/l (severely deficient), 0.7 mmol/l (moderately deficient) or 1.05 mmol/l (mildly deficient) were significantly different between cases and controls, when XN was defined as no problems seeing during the daytime, but problems seeing in low levels of light (MCD ; Table 3 ). Similarly, the mean pupillary threshold measurement was not significantly different between cases and controls using the MCD (Table 4) . Both the median serum retinol concentrations and the median pupillary threshold measurements were worse for cases than controls when the more restricted case definitions (RCD1-3) were used, but the differences were small and not statistically significant (Tables 3 and 4) . Pupillary threshold measurements were significantly worse in participants with low serum retinol concentrations of o0.7 mmol/l (-1.45 vs -1.58 log cd/m 2 , P ¼ 0.016, two-sample t-test with equal variances) and median serum retinol concentrations decreased significantly, with worsening pupillary threshold scores (P ¼ 0.05, Cuzick test for trend).
Follow-up survey and the impact of vitamin A treatment All 311 participants who had blood taken for serum retinol measurements were eligible to participate in the follow-up survey. A total of 277 (89.1%) participants attended: 136 cases (89.5%) and 141 controls (88.7%). Full follow-up data were available for 265 participants (95.7%). Of all the participants who were eligible for follow-up, 256 participants (256/311 ¼ 82.3%) provided complete data both at baseline and follow-up. Both cases and all five controls who had Bitot's spots at the baseline survey received a treatment course of vitamin A. Two of these controls did not attend the follow-up survey.
Impact of vitamin A treatment on serum retinol concentration and on pupillary threshold measurements Median serum retinol concentrations increased significantly in treated (0.13 mmol/l) vs untreated young children (0.02 mmol/l; P ¼ 0.002, median regression), and a significantly lower proportion of treated than untreated children had serum retinol concentrations below 0.7 mmol/l (31.1 vs 52.3%; Po0.001, w 2 test with Yates correction). Also in primary school-age children, the median serum retinol concentration increased more in treated (0.13 mmol/l) than in untreated (0.04 mmol/l) participants. However, this difference was not statistically significant (P ¼ 0.371, median regression), and the proportions with serum retinol concentrations below 0.7 mmol/l were small but similar (5/44 treated vs 4/45 untreated; P ¼ 0.739, Fisher's exact test). The median serum retinol concentrations decreased both in treated and untreated women (0.15 vs 0.09 mmol/l; P ¼ 0.244, median regression) and a higher proportion of treated women had low serum retinol concentrations (o0.7 mmol/l) at follow-up. However, these differences were not statistically significant (7/40 vs 4/38; P ¼ 0.576, w 2 test with Yates correction). Pupillary threshold scores improved more in treated cases than in untreated controls for all definitions of XN in all three population groups. These differences were statistically significant for RCD1-3 in young children and primary school-age children (Table 5) .
Discussion
Prevalence of VAD in the study population According to WHO guidelines, the following findings in children between 12 months (24 months for XN reports) and 71 months are indicators of VAD as a public health problem in a community (World Health Organization, 1996) : Biochemical: at least 10% of children between 12 and 71 months with serum retinol concentrations of 0. 7 mmol/l or less. Clinical (xerophthalmia): a minimum prevalence of reported XN of 1.0%, Bitot's spots of 0.5% and/or corneal scars of 0.05%.
A threshold for serum retinol concentration of o0.7 mmol/ l in at least 15% of a representative group of preschool-age children between 6 and 71 months of age was proposed at a recent IVACG meeting (de Pee & Dary, 2002) . Low serum retinol concentrations were common in the screened population of young children aged 24-71 months. In all, 56.4% (57/101) had serum retinol concentrations of 0.7 mmol/l or less, and 7.7% (8/101) were below 0.35 mmol/l. Validation of night blindness reports in rural Tanzania SH Wedner et al Also, the prevalence of signs and symptoms of xerophthalmia were well above the WHO thresholds, with the prevalence of XN reports in 24-to 71-month-olds ranging between 2.8% (RCD3) and 11.7% (MCD) depending on the definition used. Bitot's spots were detected in five (0.7%) of the young children and corneal scars in two (0.4%), even though in one of these the appearance of the scar indicated a corneal foreign body in the past as the likely cause, which left one child (0.2%) whose scars might have been due to VAD. No guidelines have been provided for biochemical indicators to define VAD as a public health problem in older children or adults. However, the second National Health and Nutrition Examination Survey (NHANES II) and the Hispanic equivalent (HHANES) reported mean serum retinol concentrations in 6-to 8-y-olds between 1.05 (HHANES girls) and 1.16 mmol/l (NHANES boys) and in 9-to 11-y-olds between 1.15 (HHANES girls and boys) and 1.22 mmol/l (NHANES boys) (Lewis et al, 1990) . These were considerably higher than the median serum retinol concentrations in comparable age groups in the Tanzanian school-age children. Similar to other school-age populations, the distribution of serum retinol concentrations in primary school-age children increased with age (P ¼ 0.027; Table 2 ) (Lewis et al, 1990; Malvy et al, 1993) .
In women, the median serum retinol concentration of 1.13 (1.04-1.29) mmol/l was similar to a group of breastfeeding women in Indonesia receiving placebo treatment (1.08-1.31 mmol/l depending on duration of postpartum interval) and just above the 5th percentile for female residents between 18 and 45 y in the United States (Olson, 1996) . A recent study of dark adaptation patterns in pregnant Ethiopian women suggested that the cutoff value for serum retinol to define VAD in pregnant women should be higher than 1.23 mmol/l (Wondmikun, 2002) .
The populations screened were self-selected attenders at the free screening clinics, and village leaders and health centre staff had been asked to particularly encourage poor and malnourished members of their communities to attend, in order for there to be the maximum number of vitamin A deficient participants for the validation study that was the primary research objective. The prevalence of clinical indicators of VAD and the low serum retinol concentrations may therefore not reflect the situation in the general population in this area of Tanzania.
XN validation study
Validation of XN reports is problematic since there are no perfect indicators of VAD, and several indicators such as serum retinol concentrations and pupillary threshold measurements are only recommended for assessment of the vitamin A status of a population but not of an individual. Also, XN or even acute corneal xerophthalmia can be found in individuals with serum retinol concentrations of 0.7 mmol/l or higher (Sommer & West, 1996) and, conversely, some individuals with low serum retinol concentrations do not have XN. On the other hand, in Indonesia, 82% of children with XN reports but no other signs of xerophthalmia were vitamin A deficient (r0.7 mmol/l) (Sommer et al, 1980) . In the Tanzanian children aged 24-71 months in this study, only 49% of the children who were reported to have XN had serum retinol concentrations of less than 0.7 mmol/l. If XN reports were a valid indicator in this population, we would expect lower serum retinol concentrations in cases than in controls. However, using the MCD, serum retinol concentrations were similar in all the population groups as were the proportion of participants with serum retinol concentrations below 0.35 and 0.7 mmol/l. Using the more restricted case definitions, which are likely to be more specific, reduced the prevalence of reported XN in each subgroup substantially. Despite this, the differences between cases and controls were small and not statistically significant, even though they went in the expected direction in primary school-age children and in women. Furthermore, for RCD1, breast-feeding women were under-represented among the cases and over-represented among the controls (pregnant cases:controls ¼ 10/16 vs breast-feeding case:control ¼ 4/33; P ¼ 0.014, Fisher's exact test). This will have increased the difference in serum retinol concentration between cases and controls, as breast-feeding women had a higher serum retinol concentration than pregnant women. The distributions of potential risk factors that have been shown to be associated with maternal XN in previous studies (eg young age, high parity or short interval since previous delivery) were not significantly different between cases and controls (Table 1b) (Katz et al, 1995) .
As for serum retinol concentrations, the pupillary threshold device has only been shown to be valid at the population level (Sanchez et al, 1997) . Still it should be a superior tool to serum retinol concentrations for evaluating XN reports, as it measures impaired dark adaptation directly. Mean pupillary threshold measurements in all three subgroups were similar in cases and controls using the MCD. This was also true for the more restricted case definitions. Even though in young children, cases had worse pupillary threshold measurements than controls, these differences were not statistically significant. However, as in previous studies in young Indian and Indonesian children and pregnant/breast-feeding women in Nepal (Congdon et al, 1995) , poor pupillary thresholds were significantly associated with low serum retinol concentration in Tanzanian children and women.
The mean pupillary threshold measurements in this Tanzanian population were surprisingly good (Table 4) compared with those detected in vitamin A deficient populations in India (-0.622 log cd/m 2 ), Indonesia (-0.985 log cd/m 2 ) and Nepal (-1.11 to -1.24 log cd/m 2 ) (Congdon et al, 1995; Sanchez et al, 1997; Congdon et al, 2000) . As the study population was clearly vitamin A deficient, one potential explanation for this unexpected result could be that waiting in a fairly dark room prior to dark adaptation decreased the participants' threshold. In Kenyan school children, ambient light conditions prior to testing have been shown to be a significant predictor of dark adaptation threshold (Nathan Congdon, personal communication).
Impact of vitamin A treatment on serum retinol concentrations and pupillary threshold scores Treatment with three 200 000 IU doses of vitamin A increased serum retinol concentrations significantly only in the most deficient group, the young children. The decrease of serum retinol concentrations despite treatment in the pregnant and breast-feeding cases indicates that a dosage of 10 000 IU daily may be insufficient to counteract the increased need for vitamin A in pregnancy and during lactation, especially in women who already have poor vitamin A status. Also, it is likely that compliance was worse as the vitamin A tablets had to be taken daily as opposed to a single course of three high-dose capsules, the first of which was taken under supervision.
Pupillary dark adaptation measurements improved consistently in cases after treatment. The improvements were significant for RCD1-3 which were more likely to identify true cases.
Conclusions
1. XN reports (using various case definitions) were a poor indicator of VAD in this rural Tanzanian population, where there is no term for XN in the local language. This finding suggests that the use of XN reports as an indicator of VAD may be questionable in populations that do not have a specific term for XN in their local language, unless they have been shown to be valid in local studies. 2. There is an urgent need for further validation studies of XN reports, especially in Africa and in populations without a specific term for XN. This is particularly important as XN reports are usually the most prevalent and simplest indicator of VAD, and are widely used in surveys to define whether public health interventions are needed and to monitor subsequent programme progress. 3. Modifying the XN case definitions changed the prevalence of reported XN substantially. Studies using XN as an indicator for VAD should therefore use a standard definition (eg the WHO definition) for XN, and the exact definition that was used should be stated in reports. 4. Although relatively time-consuming, the pupillary threshold test proved feasible, acceptable and repeatable, particularly in participants aged 3 y and above. It also showed a significant response to dosing in young children and primary school-age children with vitamin A when the restricted case definitions were used. However, the substantial differences in the absolute measurements between this Tanzanian population and those found in other vitamin A deficient populations merit further investigation.
